EZECOR

Nazione: Israele

Lingua: inglese

Fonte: Ministry of Health

Principio attivo:

EZETIMIBE

Commercializzato da:

UNIPHARM LTD, ISRAEL

Codice ATC:

C10AX09

Forma farmaceutica:

TABLETS

Composizione:

EZETIMIBE 10 MG

Via di somministrazione:

PER OS

Tipo di ricetta:

Required

Prodotto da:

UNIPHARM LTD, ISRAEL

Area terapeutica:

EZETIMIBE

Indicazioni terapeutiche:

Primary hypercholesterolemia: Ezecor administered with an HMG-CoA reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia. Homozygous familial hypercholesterolemia (HoFH): Ezecor administered with a statin are indicated for use in patients with HoFH.Patients may also receive adjunctive treatments (e.g. LDL apheresis).Homozygous sitosterolemia (Phytosterolemia): Ezecor are indicated for use in patients with homozygous familial sitosterolemia.

Data dell'autorizzazione:

2021-04-30

Foglio illustrativo

PATIENT
PACKAGE
INSERT
IN
ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS )PREPARATIONS( – 1986
The medicine is dispensed with
a doctor’s prescription only
EZECOR
TABLETS
COMPOSITION
Each tablet contains:
Ezetimibe 10 mg
For the list of inactive and allergenic
ingredients in the preparation, see section
6: “Further information” and section 2: “Before
using the medicine”.
READ THE LEAFLET CAREFULLY IN ITS ENTIRETY
BEFORE USING THE MEDICINE.
• This leaflet contains concise information
about the medicine. If you have further
questions, refer to the doctor or pharmacist.
• This medicine has been prescribed to treat
you. Do not pass it on to others. It may harm
them, even if it seems to you that their
medical condition is similar.
• EZECOR is not intended for children under
the age of 10.
1. WHAT IS THE MEDICINE INTENDED
FOR?
EZECOR is a medicine used to lower high
levels of fat in the blood.
EZECOR is sometimes given in combination
with medicines from the statin family )e.g.,
simvastatin, atorvastatin, etc.(; in this case,
carefully read the patient leaflet of the statin
before starting treatment and consult your
doctor.
THERAPEUTIC GROUP:
Ezetimibe belongs to a group of medicines
called CAI )cholesterol absorption inhibitors(,
which inhibit the absorption of cholesterol in
the intestines.
2. BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE:
• if you are sensitive )allergic( to ezetimibe
or to any of the other ingredients
contained in the medicine )see also
section 6: “Further information”(.
• in combination with a statin, if you
currently have liver problems.
• in combination with a statin, if you are
pregnant or breastfeeding.
118888010
02B21
If you are taking EZECOR together with a
statin, please read the patient leaflet of that
additional medicine.
IF YOU THINK THAT THE ABOVE APPLIES TO
YOU, DO NOT TAKE THE MEDICINE UNTIL YOU
CONSULT WITH YOUR DOCTOR.
SPECIAL WARNINGS REGARDING USE OF THE
MEDICINE
• Tell your doctor of all your medical
conditions, including allergies.
• The doctor